查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1565022

全球核酸标籤市场

Nucleic Acid Labeling
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到2030年全球核酸标籤市场将达到48亿美元

2023年全球核酸标籤市场预计为29亿美元，预计到2030年将达48亿美元，2023年至2030年复合年增长率为7.5%。核酸标记试剂是本报告分析的细分市场之一，复合年增长率为8.3%，预计到分析期结束时将达到24亿美元。分析期间，核酸标记试剂套件领域的复合年增长率预计为 7.2%。

美国市场预估为7.975亿美元，中国预期复合年增长率为6.9%

预计2023年美国核酸标记市场规模将达7.975亿美元。中国作为世界第二大经济体，预计到 2030 年市场规模将达到 7.371 亿美元，2023-2030 年分析期间复合年增长率为 6.9%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间复合年增长率分别为 7.0% 和 6.1%。在欧洲，德国的复合年增长率预计约为 6.0%。

全球核酸标记市场－主要趋势与驱动因素总结

为什么核酸标记在现代分子生物学中很重要？

核酸标记是分子生物学和生物技术中的重要过程，可在各种研究和诊断应用中对 DNA、RNA 和其他核酸进行检测、视觉化和定量。标记可以是萤光、放射性标记或酵素标记，用于原位杂合反应、PCR、微阵列和定序等技术。这些标记技术对于研究基因表现、检测基因突变和详细了解分子交互作用至关重要。随着基因组学和精准医学研究的加速，核酸标记在临床诊断和生命科学研究中变得越来越重要，其中准确性和灵敏度至关重要。

技术进步如何形塑核酸标记市场？

核酸标记技术的进步正在推动研究和临床应用的成长。萤光标记和染料化学的创新提高了检测技术的敏感度和特异性，从而实现更清晰、更准确的结果。新一代标记试剂套件和试剂也简化了流程，减少了与传统标记方法相关的时间和复杂性。此外，自动标记系统在大规模基因组和药物研究等高通量环境中越来越受欢迎。这些进步提高了核酸标记过程的效率和扩充性，使实验室更容易处理更大的样本量和更复杂的实验。

基因组学和诊断学的兴起将如何影响核酸标记？

对基因组学和个人化医疗的日益关注正在对核酸标记市场产生重大影响。随着基因序列测定和分子诊断对医疗保健至关重要，对准确、高效的核酸标记方法的需求不断增加。在临床诊断中，标记核酸对于检测遗传疾病、感染疾病和癌症至关重要，而准确性对于确定有效的治疗方法至关重要。此外，次世代定序(NGS) 和基于 CRISPR 的基因编辑等高通量技术的发展增加了对先进标记技术的需求，这些技术可以支援遗传物质的大规模和快速分析。这一趋势也是由基因组学研究投资的增加和生物製药创新的兴起所推动的。

核酸标记市场的成长由多种因素推动

核酸标记市场的成长受到多种因素的推动，包括分子生物学技术的进步、基因组学应用的扩大以及对高精度诊断工具的需求不断增加。随着次世代定序（NGS）技术和个人化医疗的普及，对先进核酸标记方法的需求不断增加。萤光和酵素标记的创新使研究和临床环境中能够更快、更准确地获得结果。此外，自动化高通量标籤系统的采用正在增加，从而提高了实验室工作流程的效率。对癌症诊断、遗传疾病和传染性病原体的研究不断增加，进一步增加了对支持快速、灵敏的核酸检测和分析的标记技术的需求。政府对基因组研究和医疗保健进步的资助也有助于市场扩张。

受访企业范例（12家知名企业）

  • Agilent Technologies, Inc.
  • Enzo Biochem, Inc.
  • F. Hoffmann-La Roche AG
  • General Electric Company
  • Merck KgaA
  • New England Biolabs, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.
  • Vector Laboratories, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP13640

Global Nucleic Acid Labeling Market to Reach US$4.8 Billion by 2030

The global market for Nucleic Acid Labeling estimated at US$2.9 Billion in the year 2023, is expected to reach US$4.8 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Nucleic Acid Labeling Reagents, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the Nucleic Acid Labeling Kits segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$797.5 Million While China is Forecast to Grow at 6.9% CAGR

The Nucleic Acid Labeling market in the U.S. is estimated at US$797.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$737.1 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.0% CAGR.

Global Nucleic Acid Labeling Market – Key Trends & Drivers Summarized

Why Is Nucleic Acid Labeling Important in Modern Molecular Biology?

Nucleic acid labeling is a crucial process in molecular biology and biotechnology, enabling the detection, visualization, and quantification of DNA, RNA, and other nucleic acids in various research and diagnostic applications. Labels can be fluorescent, radioactive, or enzymatic, and they are used in techniques such as in situ hybridization, PCR, microarrays, and sequencing. These labeling techniques are essential for studying gene expression, detecting genetic mutations, and understanding molecular interactions at a detailed level. As research in genomics and precision medicine accelerates, nucleic acid labeling is becoming increasingly critical in both clinical diagnostics and life sciences research, where accuracy and sensitivity are paramount.

How Are Technological Advancements Shaping the Nucleic Acid Labeling Market?

Technological advancements in nucleic acid labeling are driving growth in both research and clinical applications. Innovations in fluorescent labeling and dye chemistry are enhancing the sensitivity and specificity of detection techniques, allowing for clearer and more accurate results. Next-generation labeling kits and reagents are also simplifying the process, reducing the time and complexity involved in traditional labeling methods. Additionally, automated labeling systems are gaining popularity in high-throughput environments, such as large-scale genomic studies and pharmaceutical research. These advancements are improving the efficiency and scalability of nucleic acid labeling processes, making it easier for laboratories to handle larger sample volumes and more complex experiments.

What Impact Does the Rise of Genomics and Diagnostics Have on Nucleic Acid Labeling?

The increasing focus on genomics and personalized medicine is significantly influencing the nucleic acid labeling market. As genetic sequencing and molecular diagnostics become more integral to healthcare, the demand for accurate and efficient nucleic acid labeling methods is rising. In clinical diagnostics, labeled nucleic acids are essential for detecting genetic disorders, infectious diseases, and cancers, where precision is critical for effective treatment decisions. In addition, the growth of high-throughput technologies, such as next-generation sequencing (NGS) and CRISPR-based gene editing, is expanding the need for advanced labeling techniques that can support large-scale, rapid analysis of genetic material. This trend is also being driven by increasing investments in genomics research and the rise of biopharmaceutical innovations.

Growth in the Nucleic Acid Labeling Market Is Driven by Several Factors

Growth in the nucleic acid labeling market is driven by several factors, including advancements in molecular biology techniques, the expanding application of genomics, and the rising demand for high-precision diagnostic tools. The proliferation of next-generation sequencing (NGS) technologies and the growing use of personalized medicine are increasing the need for sophisticated nucleic acid labeling methods. Technological innovations in fluorescent and enzymatic labeling are enabling faster, more accurate results in both research and clinical settings. Additionally, the increasing adoption of automated and high-throughput labeling systems is enhancing workflow efficiency in laboratories. Growing research into cancer diagnostics, genetic diseases, and infectious pathogens is further fueling demand for labeling technologies that support rapid, sensitive nucleic acid detection and analysis. Government funding for genomics research and healthcare advancements is also contributing to the market’s expansion.

Select Competitors (Total 12 Featured) -

  • Agilent Technologies, Inc.
  • Enzo Biochem, Inc.
  • F. Hoffmann-La Roche AG
  • General Electric Company
  • Merck KgaA
  • New England Biolabs, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.
  • Vector Laboratories, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Nucleic Acid Labeling - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Molecular Diagnostics and Research Drives Growth in Nucleic Acid Labeling Applications
    • Advances in Fluorescent and Radioactive Labeling Technologies Expand Opportunities in DNA/RNA Labeling for Diagnostics
    • Rising Use of Nucleic Acid Labeling in Next-Generation Sequencing (NGS) and PCR Amplification Fuels Market Demand
    • Expanding Role of Genetic and Epigenetic Research Spurs the Adoption of Novel Nucleic Acid Labeling Methods
    • Growing Importance of Gene Expression Profiling Strengthens the Business Case for Labeling Techniques in Transcriptomics
    • Development of Cost-Effective and High-Sensitivity Labeling Kits Propels Growth in Clinical and Research Applications
    • Increasing Adoption of In-Situ Hybridization (ISH) Techniques Drives Demand for High-Precision Nucleic Acid Labeling
    • Growing Role of CRISPR-Based Research in Gene Editing Expands the Need for Advanced Nucleic Acid Labeling Technologies
    • Rising Focus on Personalized Medicine and Biomarker Discovery Spurs Market Demand for Innovative Labeling Solutions
    • Advances in Non-Radioactive Labeling Techniques Propel Growth in Safe and Environmentally Friendly Labeling Solutions
    • Rising Use of Labeling in Single-Cell Analysis Strengthens Demand for High-Specificity Nucleic Acid Labeling Kits
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Nucleic Acid Labeling Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Nucleic Acid Labeling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Nick Translation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Nick Translation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Random Primer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Random Primer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for In Vitro Transcription by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for In Vitro Transcription by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Reverse Transcription by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Reverse Transcription by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Labeling Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World 7-Year Perspective for Other Labeling Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for in Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World 7-Year Perspective for in Situ Hybridization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 25: World 7-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World 7-Year Perspective for Polymerase Chain Reaction (PCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Fluorescence in Situ Hybridization (FISH) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: World 7-Year Perspective for Fluorescence in Situ Hybridization (FISH) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 31: World 7-Year Perspective for Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Blotting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World 7-Year Perspective for Blotting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 34: USA Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: USA 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: USA 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • CANADA
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Canada 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Canada 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • JAPAN
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Japan 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Japan 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • CHINA
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 52: China Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: China 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 54: China Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: China 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • EUROPE
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 58: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 59: Europe 7-Year Perspective for Nucleic Acid Labeling by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Europe 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Europe 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • FRANCE
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 66: France Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 67: France 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 70: France Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 71: France 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • GERMANY
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 72: Germany Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 73: Germany 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 76: Germany Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 77: Germany 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • ITALY
    • TABLE 78: Italy Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 79: Italy 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 82: Italy Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 83: Italy 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • UNITED KINGDOM
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 84: UK Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 85: UK 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 88: UK Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 89: UK 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 91: Rest of Europe 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 95: Rest of Europe 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 97: Asia-Pacific 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 101: Asia-Pacific 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 102: Rest of World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 103: Rest of World 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of World 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
    • TABLE 106: Rest of World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 107: Rest of World 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030

IV. COMPETITION